GeneDx Holdings (WGS) saw its stock price drop sharply by 5.07% during intraday trading on Tuesday, reflecting investor concerns following mixed analyst opinions on the company.
The healthcare sector, including GeneDx Holdings, has been under scrutiny as analysts weigh in on its performance. The mixed reviews may have contributed to the sell-off, as investors reacted to the uncertainty surrounding the company's outlook.